IOPIDINE

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Finland, France, Ireland, Israel, Malta, Netherlands, New Zealand, Tunisia, UK.

Active ingredients

The drug IOPIDINE contains one active pharmaceutical ingredient (API):

1	Apraclonidine UNII D2VW67N38H - APRACLONIDINE HYDROCHLORIDE
	Apraclonidine is an α2-adrenergic receptor agonist and a weak α1-adrenergic receptor agonist. It is used for the prevention and treatment of postsurgical intraocular pressure elevation.
	Read more about Apraclonidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Iopidine 0.5% Ophthalmic solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
IOPIDINE Eye drops, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EA03	Apraclonidine	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EA Sympathomimetics in glaucoma therapy
Discover more medicines within S01EA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8083K
CA	Health Products and Food Branch	00888354, 02076306
FI	Lääkealan turvallisuus- ja kehittämiskeskus	124685, 161950
FR	Base de données publique des médicaments	60941378, 63218293
GB	Medicines & Healthcare Products Regulatory Agency	142546, 37991, 39563
IE	Health Products Regulatory Authority	63844
IL	מִשְׂרַד הַבְּרִיאוּת	3028
MT	Medicines Authority	MA1149/00201
NL	Z-Index G-Standaard	13968904, 14133210
NL	Z-Index G-Standaard, PRK	43273, 47880
NZ	Medicines and Medical Devices Safety Authority	6197
TN	Direction de la Pharmacie et du Médicament	6643131
US	FDA, National Drug Code	0065-0660